Retinoblastoma and treatment: A current evaluation of advanced therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

321

HTML

2814

Tables (1-2)

287

Sum=3422

Sep 9, 2013 (publication date) through Mar 10, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Pharmacol. Sep 9, 2013; 2(3): 65-72
Published online Sep 9, 2013. doi: 10.5497/wjp.v2.i3.65

Table 1 Reese-Ellsworth classification

Group	Globe salvage likelihood	Features
I	Very favorable	< 4 disc diameters at or behind equator
		(1) solitary
		(2) multiple
II	Favorable	4-10 disc diameters, at or behind equator
		(1) solitary
		(2) multiple
III	Doubtful	(1) anterior to equator
		(2) solitary, > 10 disc diameter behind equator
IV	Unfavorable	(1) multiple tumors, some > 10 disc diameters
		(2) lesion extends anteriorly to ora serrata
V	Very unfavorable	(1) tumors occupying over 50% of retina
	Very unfavorable	(2) vitreous seeding

Source: Adapted from[56].

Citation: Shah NV, Houston SK, Murray TG. Retinoblastoma and treatment: A current evaluation of advanced therapy. World J Pharmacol 2013; 2(3): 65-72
URL: https://www.wjgnet.com/2220-3192/full/v2/i3/65.htm
DOI: https://dx.doi.org/10.5497/wjp.v2.i3.65